Angiogenin (108-122) is an angiogenin peptide that serves as a therapeutic agent for the prophylaxis and or treatment of cancer, infectious diseases, fibroticdiseases, inflammatory diseases, neurodegenerative diseases, and autoimmune conditions.
PAT-347 is a potent Autotaxin Inhibitor. Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. The ATX-LPA signaling pathway is implicated in cell survival, migration, and proliferation; thus, the inhibition of ATX is a recognized therapeutic target for a number of diseases including fibroticdiseases, cancer, and inflammation, among others.